Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

882247

registered interest
date	13/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Motor Neurone Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to his Oral Answer of 20 March 2018, Official Report, column 156, on motor neurone disease, which projects received that £52 million investment; and which 24 clinical trials are being recruited to.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	135354
answer	answer is ministerial correction date of answer 19/04/2018 answer text <p>In 2016-17, the National Institute for Health Research (NIHR) invested £52.2 million into health research covered by the ‘Neurological conditions’ category of the UK Health Research Classification System. This £52.2 million was used to fund and support a range of research studies and research infrastructure for neurological conditions and within that, £4.58 million was spent specifically on Motor Neurone Disease (MND) and closely-related conditions.</p><p> </p><p>The NIHR provides the support, expertise and facilities that the NHS needs to undertake world-leading research funded by the NIHR, and other public, charity and life sciences industry partners, by funding a range of infrastructure facilities.</p><p> </p><p>The NIHR Clinical Research Network is currently supporting 19 non-commercial studies and clinical trials on MND and closely-related conditions which are open and recruiting participants. The non-commercial studies are listed in the table below. There are currently two commercial studies which are also recruiting participants.</p><p> </p><p>In 2016-17, the NIHR Research Infrastructure supported 23 studies and trials on MND and closely-related conditions in the NIHR Biomedical Research Centres, Units and other research infrastructure. The majority of these studies have been funded by research charities including the Motor Neurone Disease Association, other research funders and the life sciences industry.</p><p> </p><p>NIHR Clinical Research Network supported Non-Commercial studies on MND and closely-related conditions which are open and recruiting participants</p><table><tbody><tr><td><p>CPMS Study ID</p></td><td><p>Study Short Name</p></td></tr><tr><td><p>12497</p></td><td><p>Trajectories of Outcome in Neurological Conditions Phase 3 Consent and questionnaire</p></td></tr><tr><td><p>12495</p></td><td><p>Trajectories of Outcome in Neurological Conditions Phase 2 Demographics and Clinical Info</p></td></tr><tr><td><p>12768</p></td><td><p>Motor System Genomics, version 1.0</p></td></tr><tr><td><p>6160</p></td><td><p>ALS Biomarkers Study</p></td></tr><tr><td><p>35238</p></td><td><p>Tonic 2 Phase 4</p></td></tr><tr><td><p>20690</p></td><td><p>MND Register for England, Wales and Northern Ireland</p></td></tr><tr><td><p>12118</p></td><td><p>Trajectories of Outcome in Neurological Conditions Phase 1</p></td></tr><tr><td><p>13182</p></td><td><p>CSF collection in patients with neurodegenerative diseases</p></td></tr><tr><td><p>16242</p></td><td><p>BioMOx Phase 2: The Oxford Study for Biomarkers in Motor Neuron Disease</p></td></tr><tr><td><p>31877</p></td><td><p>A Multicentre Biomarker Study in Neurodegeneration</p></td></tr><tr><td><p>20372</p></td><td><p>Contributing clinical MRI scans to multi-centre collaboration</p></td></tr><tr><td><p>19128</p></td><td><p>Tongue EIM</p></td></tr><tr><td><p>17831</p></td><td><p>Using MRI to investigate energy metabolism in MND</p></td></tr><tr><td><p>34909</p></td><td><p>Improving support for family and friends caring for people with MND</p></td></tr><tr><td><p>35042</p></td><td><p>Serial fasciculation measurements in motor neurone disease</p></td></tr><tr><td><p>17557</p></td><td><p>Care Augmentation by Location-linked messaging CALL-Me</p></td></tr><tr><td><p>32678</p></td><td><p>MIROCALS_H2020/PHRC-N/2014/GB-01_ID-IL-2_Neuro-Inflammation in ALS Pts</p></td></tr><tr><td><p>36434</p></td><td><p>Change in MND</p></td></tr><tr><td><p>37175</p></td><td><p>ProSec 3</p></td></tr></tbody></table> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 19/04/2018 14:15:01 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	151 label Biography information for Tom Brake

882434

registered interest
date	13/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Department of Health and Social Care: Public Expenditure
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Written Statement of 13 March 2018, Spring Statement, HCWS 540, if he will publish a list of where the £21.1 million in EU exit funding for his Department will be allocated.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	135496
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>The Department has been allocated £21.1 million for staff to support essential European Union exit preparations in 2018-19. This will include ongoing work in all relevant areas of the Department, such as reciprocal healthcare, ensuring that the safety of both United Kingdom and EU patients is protected. As with all Reserve funding, finalised allocations will be confirmed at Supplementary Estimates 2018-19 in early 2019. There are no plans to publish a detailed list.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 23/04/2018 12:27:04 answering member 4095 label Biography information for Steve Barclay
tabling member	151 label Biography information for Tom Brake

882485

registered interest
date	13/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Postnatal Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to add the maternal six week postnatal check to the General Medical Contract as recommended by the National Childbirth Trust.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	135547
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>Currently, the Department has no plans to add the maternal six week postnatal check to the General Medical Services Contract as recommended by the National Childbirth Trust.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) guidance, Postnatal care up to 8 weeks after birth states “At the end of the postnatal period, the coordinating healthcare professional should ensure that the woman’s physical, emotional and social wellbeing is reviewed.” NHS England expects commissioners and providers of maternity care to pay due regard to the NICE guidelines.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 16:08:35 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake